"Seeing" in NARCOMS: A look at vision-related quality of life in the NARCOMS registry

Multiple Sclerosis Journal

Volumn 19, Issue 7, 2013, Pages 953-960

  Salter, Amber R ^a   Tyry, Tuula ^b   Vollmer, Timothy ^c   Cutter, Gary R ^a   Marrie, Ruth Ann ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

cohort studies; health care utilization; MS; Multiple sclerosis; quality of life; vision

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CONTACT LENS; DIPLOPIA; DISEASE DURATION; DISEASE REGISTRY; EYE CARE; FEMALE; HUMAN; HYPERMETROPIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYOPIA; OPTIC NEURITIS; QUALITY OF LIFE; REFRACTION ERROR; RISK ASSESSMENT; SPECTACLES; UVEITIS; VISUAL AID; VISUAL IMPAIRMENT;

EID: 84878371259     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512469694     Document Type: Article

References (37)

1. McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry. 1992 ; 55: 747-752
2. Sorensen TL, Frederiksen JL, Bronnum-Hansen H, et al. Optic neuritis as onset manifestation of multiple sclerosis: A nationwide, long-term survey. Neurology. 1999 ; 53: 473-478
3. Frohman EM, Frohman TC, Zee DS, et al. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol. 2005 ; 4: 111-121
4. Arnold AC. Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol. 2005 ; 139: 1101-1108
5. Pawar VS, Pawar G, Miller L-A, et al. Impact of visual impairment on health-related quality of life in multiple sclerosis. Int J MS Care. 2010 ; 12: 83-91
6. Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998 ; 116: 1496-1504
7. Mowry EM, Loguidice MJ, Daniels AB, et al. Vision related quality of life in multiple sclerosis: Correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry. 2009 ; 80: 767-772
8. Ma SL, Shea JA, Galetta SL, et al. Self-reported visual dysfunction in multiple sclerosis: New data from the VFQ-25 and development of an MS-specific vision questionnaire. Am J Ophthalmol. 2002 ; 133: 686-692
9. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001 ; 119: 1050-1058
10. Noble J, Forooghian F, Sproule M, et al. Utility of the National Eye Institute VFQ-25 questionnaire in a heterogeneous group of multiple sclerosis patients. Am J Ophthalmol. 2006 ; 142: 464-468
11. Marrie RA, Goldman M. Validity of performance scales for disability assessment in multiple sclerosis. Mult Scler. 2007 ; 13: 1176-1182
12. Atkins EJ, Drews-Botsch CD, Newman NJ, et al. Management of optic neuritis in Canada: Survey of ophthalmologists and neurologists. Can J Neurol Sci. 2008 ; 35: 179-184
13. Calvetti O, Vignal-Clermont C, Drews-Botsch CD, et al. Management of isolated optic neuritis in France: Survey of neurologists and ophthalmologists [in French]. Rev Neurol (Paris). 2008 ; 164: 233-241
14. Marrie RA, Cutter G, Tyry T, et al. Validation of the NARCOMS registry: diagnosis. Mult Scler. 2007 ; 13: 770-775
15. Marrie R, Horwitz R, Cutter G, et al. Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler. 2008 ; 14: 1091-1098
16. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: A longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler. 1999 ; 5: 349-354
17. Schwartz CE, Vollmer T, Lee H, et al. Reliability and validity of two self-report measures of impairment and disability for MS. Neurology. 1999 ; 52: 63
18. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996 ; 34: 220-233
19. Cole SR, Beck RW, Moke PS, et al. The National Eye Institute Visual Function Questionnaire: Experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci. 2000 ; 41: 1017-1021
20. Mangione CM The National Eye Institute 25-Item Visual Function Questionnaire: Scoring algorithm. Bethesda, MD: The National Eye Institute ; 1997 :
21. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006 ; 113: 324-332
22. Collins J. Prevalence of selected chronic conditions, United States, 1986-88. Vital Health Stat. 1993 ; 10 ( 1 62 ):
23. Jacobs LD, Wende KE, Brownscheidle CM, et al. A profile of multiple sclerosis: The New York State Multiple Sclerosis Consortium. Mult Scler. 1999 ; 5: 369-376
24. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004 ; 122: 477-485
25. Vitale S, Ellwein L, Cotch MF, et al. Prevalence of refractive error in the United States, 1999-2004. Arch Ophthalmol. 2008 ; 126: 1111-1119
26. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992 ; 99: 1499-1504
27. Congdon N, Vingerling JR, Klein BE, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004 ; 122: 487-494
28. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004 ; 111: 491-500
29. Langer-Gould A, Albers KB, Van Den Eeden SK, et al. Autoimmune diseases prior to the diagnosis of multiple sclerosis: A population-based case-control study. Mult Scler. 2010 ; 16: 855-861
30. Le Scanff J, Seve P, Renoux C, et al. Uveitis associated with multiple sclerosis. Mult Scler. 2008 ; 14: 415-417
31. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003 ; 290: 2057-2060
32. Marrie RA, Cutter G, Tyry T. Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis. Mult Scler. 2011 ; 17: 1464-1471
33. Armstrong J. Environics poll: Public awareness and attitudes about age-related macular degeneration. The Cost of Blindness: What it means to Canadians ; Toronto, Ontario, Canada ;..
34. Balcer LJ, Baier ML, Kunkle AM, et al. Self-reported visual dysfunction in multiple sclerosis: Results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). Mult Scler. 2000 ; 6: 382-385
35. McGwin G, Khoury R, Cross J, et al. Vision impairment and eye care utilization among Americans 50 and older. Curr Eye Res. 2010 ; 35: 451-458
36. Centers for Disease Control. Office of Surveillance, Epidemiology, and Laboratory Services Behavioral Risk Factor Surveillance System. About the BRFSS, http://www.cdc.gov/brfss/about.htm (2008, accessed 27 September 2012).
37. Horton M, Rudick RA, Hara-Cleaver C, et al. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology. 2010 ; 35: 83-90